Skip to main content

Animations

MJFF Publications

541 - 550 of 8620 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2018
  • 2018
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • Summary Details
    RESTRICTED
    Title: ID:16203 Brachial Plexus Stimulation for Refractory Neuropathic Upper Limb Pain in a Traumatic Brain Injury Patient
    Journal Name: Neuromodulation: Technology at the Neural Interface
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurom.2022.02.011
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Special Issue on new therapeutic approaches to Parkinson disease
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.108998
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approach
    Journal Name: Neuropeptides
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.npep.2022.102283
    Best OA location URL:
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Genetic analysis of neurodegenerative diseases in a pathology cohort
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.11.007
    Best OA location URL:
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Common and rare GCH1 variants are associated with Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.09.008
    Best OA location URL:
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Miro1 Marks Parkinson’s Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson’s Models
    Journal Name: Cell Metabolism
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.cmet.2019.08.023
    Citation Count: 139
  • Summary Details
    OPEN
    Title: Prediction of cognitive progression in Parkinson's disease using three cognitive screening measures
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2019.08.006
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Cognitive processes that indirectly affect olfactory dysfunction in Parkinson's disease
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2019.07.003
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Nutritional ketosis for mild cognitive impairment in Parkinson's disease: A controlled pilot trial
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2019.07.006
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Dopamine effects on frontal cortical blood flow and motor inhibition in Parkinson's disease
    Journal Name: Cortex
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.cortex.2019.01.016
    Citation Count: 30
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.